Oyster Point Pharma

Oyster Point Pharma is a commercial-stage biopharmaceutical company developing therapies for ophthalmic diseases.

Viatris
Pharma

Viatris says its divestures, return to growth strategy on track

The company expects to announce three divestures this year, with one coming in the current quarter.
Zoey Becker Aug 9, 2023 9:10am
Viatris

Viatris enters ophthalmology arena with Oyster Point buyout

Nov 7, 2022 11:58am